Bidwill Trust Hospital

Name :

Bidwill Trust Hospital

Address  :

53 Elizabeth St
South Canterbury

Town  :

Timaru

State  :

Canterbury

Country  :

NEW ZEALAND

Post Code:

7910

Phone  :

03 684 5082

Fax  :

03 688 0542

Web URL  :

Specialization
  • Colon & Rectal Surgeon
  • Dermatology
  • ENT
  • General Surgeon
  • Gynaecology
  • Maxillofacial Surgery
  • Ophthalmology
  • Orthopedics
  • Paediatrics
  • Vascular Surgeon
Facilities

Total Number Of Beds : 28


Description

Bidwill Trust Hospital is a modern purpose built private surgical hospital with facilities that are comparable with the best in New Zealand The hospital was rebuilt in 2001 having provided health services to the people of South Canterbury since 1912

With just 14 inpatient beds and a 14 bed day surgery unit Bidwill is small enough to provide quality personalised care and attention There are three fully equipped operating theatres

Bidwill is the only private surgical hospital in the South Canterbury region offering an extensive range of services including general surgery orthopaedics ophthalmology ENT oral and gynaecology The hospital is a charitable trust and all profits are invested back into the hospital ensuring that the best equipment and facilities are maintained The hospital has a three year certification from the Ministry of Health and is ISO 9002 accredited The hospital is a Southern Cross Affiliated Provider and holds cataract endoscopy and varicose vein contracts

Disclaimer Whilst we take steps to ensure that all of the information presented is accurate Bidwill Trust Hospital can not be held accountable for the accuracy of any information provided
Plan to reduce heart patient wait times

Cardiologists around New Zealand are watching a pilot project at Waikato Hospital in the hope it will help reduce treatment times for acute coronary syndrome The number of patients going to hospital emergency departments with symptoms of the syndrome which include chest pain nausea and sweating is rising nationwide putting pressure on bed availa... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More